Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2024

Open Access 01-12-2024 | Hypertension | Research

Relationship between TyG index and the degree of coronary artery lesions in patients with H-type hypertension

Authors: Zhengwen Xu, Peixian Chen, Lian Wang, Jie Yan, Xisheng Yan, Dongsheng Li

Published in: Cardiovascular Diabetology | Issue 1/2024

Login to get access

Abstract

Background

The TyG index, a prominent metric for assessing insulin resistance, has gained traction as a prognostic tool for cardiovascular disease. Nevertheless, the understanding of the prognostic significance of the extent of coronary artery stenosis in individuals afflicted with H-type hypertension remains limited.

Methods

A retrospective study was conducted at Wuhan Third Hospital, including a cohort of 320 inpatients who were diagnosed with hypertension in combination with coronary artery disease. The study period spanned from January 1, 2021, to February 1, 2023. The study cohort was stratified based on the severity of stenosis into three distinct groups: low stenosis, medium stenosis, and high stenosis, as determined by the Gensini score derived from coronary angiography findings. The present study aimed to investigate the association between the severity of coronary stenosis and the number of lesion branches, utilizing the TyG index as a testing indicator. The predictive ability of TyG for coronary lesion severity was assessed using logistic regression analysis.

Results

The results of our study indicate a positive correlation between elevated levels of TyG and an increased susceptibility to severe stenosis in individuals diagnosed with H-type hypertension. Upon careful consideration of potential confounding variables, it has been observed that the TyG index exhibits a robust association with the likelihood of severe stenosis in individuals with H-type hypertension (odds ratio [OR] = 4000, 95% confidence interval CI 2.411–6.635, p = 0.0001), as well as the prevalence of multivessel disease (OR = 1.862, 95% CI 1.036–3.348, p < 0.0001). The TyG index demonstrated superior predictive ability for severe coronary stenosis in patients with H-type hypertension compared to those without H-type hypertension (area under the curve [AUC] = 0.888, 95% confidence interval CI 0.838–0.939, p < 0.0001, versus AUC = 0.615, 95% CI 0.494–0.737, p < 0.05).

Conclusion

The TyG index is an independent risk factor for the degree of coronary stenosis and a better predictor in patients with H-type hypertension combined with coronary artery disease.
Literature
1.
go back to reference Yang G, Wang Y, Zeng Y, et al. Rapid health transition in China, 1990–2010: findings from the global burden of disease study 2010. Lancet. 2013;381(9882):1987–2015.PubMedPubMedCentralCrossRef Yang G, Wang Y, Zeng Y, et al. Rapid health transition in China, 1990–2010: findings from the global burden of disease study 2010. Lancet. 2013;381(9882):1987–2015.PubMedPubMedCentralCrossRef
2.
go back to reference Jiang L, Krumholz HM, Li X, et al. Achieving best outcomes for patients with cardiovascular disease in China by enhancing the quality of medical care and establishing a learning health-care system. Lancet. 2015;386(10002):1493–505.PubMedPubMedCentralCrossRef Jiang L, Krumholz HM, Li X, et al. Achieving best outcomes for patients with cardiovascular disease in China by enhancing the quality of medical care and establishing a learning health-care system. Lancet. 2015;386(10002):1493–505.PubMedPubMedCentralCrossRef
3.
go back to reference Z. W, Z. C, L. Z, et al. Status of hypertension in China: results from the china Z. W, Z. C, L. Z, et al. Status of hypertension in China: results from the china
4.
go back to reference Hypertension survey, 2012–2015. Circulation, 2018. Hypertension survey, 2012–2015. Circulation, 2018.
5.
go back to reference Guo QH, Zhang YQ, Wang JG. Asian management of hypertension: Current status, home blood pressure, and specific concerns in China. J Clin Hypertens. 2020;22(3):475–8.CrossRef Guo QH, Zhang YQ, Wang JG. Asian management of hypertension: Current status, home blood pressure, and specific concerns in China. J Clin Hypertens. 2020;22(3):475–8.CrossRef
6.
go back to reference Chen Z, Wang F, Zheng Y, et al. H-type hypertension is an important risk factor of carotid atherosclerotic plaques. Clin Exp Hypertens. 2016;38(5):424–8.PubMedCrossRef Chen Z, Wang F, Zheng Y, et al. H-type hypertension is an important risk factor of carotid atherosclerotic plaques. Clin Exp Hypertens. 2016;38(5):424–8.PubMedCrossRef
7.
go back to reference Qian XL, Cao H, Zhang J, et al. The prevalence, relative risk factors and MTHFR C677T genotype of H type hypertension of the elderly hypertensives in Shanghai, China: a cross-section study : prevalence of H type hypertension. BMC Cardiovasc Disord. 2021;21(1):376.PubMedPubMedCentralCrossRef Qian XL, Cao H, Zhang J, et al. The prevalence, relative risk factors and MTHFR C677T genotype of H type hypertension of the elderly hypertensives in Shanghai, China: a cross-section study : prevalence of H type hypertension. BMC Cardiovasc Disord. 2021;21(1):376.PubMedPubMedCentralCrossRef
8.
go back to reference Qin X, Huo Y. H-type hypertension, stroke and diabetes in china: opportunities for primary prevention. J Diabetes. 2016;8(1):38–40.PubMedCrossRef Qin X, Huo Y. H-type hypertension, stroke and diabetes in china: opportunities for primary prevention. J Diabetes. 2016;8(1):38–40.PubMedCrossRef
9.
go back to reference Zaric BL, Obradovic M, Bajic V, et al. Homocysteine and hyperhomocysteinaemia. Curr Med Chem. 2019;26(16):2948–61.PubMedCrossRef Zaric BL, Obradovic M, Bajic V, et al. Homocysteine and hyperhomocysteinaemia. Curr Med Chem. 2019;26(16):2948–61.PubMedCrossRef
10.
go back to reference Van Guelpen B, Hultdin J, Johansson I, et al. Plasma folate and total homocysteine levels are associated with the risk of myocardial infarction, independently of each other and of renal function. J Intern Med. 2009;266(2):182–95.PubMedCrossRef Van Guelpen B, Hultdin J, Johansson I, et al. Plasma folate and total homocysteine levels are associated with the risk of myocardial infarction, independently of each other and of renal function. J Intern Med. 2009;266(2):182–95.PubMedCrossRef
11.
go back to reference Chen CJ, Yang TC, Chang C, et al. Homocysteine is a bystander for ST-segment elevation myocardial infarction: a case-control study. BMC Cardiovasc Disord. 2018;18(1):33.PubMedPubMedCentralCrossRef Chen CJ, Yang TC, Chang C, et al. Homocysteine is a bystander for ST-segment elevation myocardial infarction: a case-control study. BMC Cardiovasc Disord. 2018;18(1):33.PubMedPubMedCentralCrossRef
12.
go back to reference Lanter BB, Sauer K, Davies DG. Bacteria present in carotid arterial plaques are found as biofilm deposits which may contribute to enhanced risk of plaque rupture. mBio. 2014;5(3):01206–14.CrossRef Lanter BB, Sauer K, Davies DG. Bacteria present in carotid arterial plaques are found as biofilm deposits which may contribute to enhanced risk of plaque rupture. mBio. 2014;5(3):01206–14.CrossRef
13.
go back to reference Xu H, Liu C, Wang Q. Plaque image characteristics, hyperhomocysteinemia, and gene polymorphism of homocysteine metabolism-related enzyme (MTHFR C677T) in acute coronary syndrome. Cell Biochem Biophys. 2013;66(2):403–7.PubMedCrossRef Xu H, Liu C, Wang Q. Plaque image characteristics, hyperhomocysteinemia, and gene polymorphism of homocysteine metabolism-related enzyme (MTHFR C677T) in acute coronary syndrome. Cell Biochem Biophys. 2013;66(2):403–7.PubMedCrossRef
14.
go back to reference Wang B, Yang Y, Li X. Interaction of hypertension and insulin resistance exacerbates the occurrence of diabetes mellitus in healthy individuals. J Diabetes Res. 2022;2022:9289812.PubMedPubMedCentralCrossRef Wang B, Yang Y, Li X. Interaction of hypertension and insulin resistance exacerbates the occurrence of diabetes mellitus in healthy individuals. J Diabetes Res. 2022;2022:9289812.PubMedPubMedCentralCrossRef
15.
go back to reference Zhang Y, Wang G, Liu J, et al. Impact of hyperhomocysteinemia on insulin resistance in patients with H-type hypertension. Clin Exp Hypertens. 2018;40(1):28–31.PubMedCrossRef Zhang Y, Wang G, Liu J, et al. Impact of hyperhomocysteinemia on insulin resistance in patients with H-type hypertension. Clin Exp Hypertens. 2018;40(1):28–31.PubMedCrossRef
16.
go back to reference Da Silva AA, Do Carmo JM, Li X, et al. Role of hyperinsulinemia and insulin resistance in hypertension: metabolic syndrome revisited. Can J Cardiol. 2020;36(5):671–82.PubMedCrossRef Da Silva AA, Do Carmo JM, Li X, et al. Role of hyperinsulinemia and insulin resistance in hypertension: metabolic syndrome revisited. Can J Cardiol. 2020;36(5):671–82.PubMedCrossRef
17.
go back to reference Defronzo RA. Banting lecture from the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes. 2009;58(4):773–95.PubMedPubMedCentralCrossRef Defronzo RA. Banting lecture from the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes. 2009;58(4):773–95.PubMedPubMedCentralCrossRef
18.
go back to reference Hill MA, Yang Y, Zhang L, et al. Insulin resistance, cardiovascular stiffening and cardiovascular disease. Metabolism. 2021;119: 154766.PubMedCrossRef Hill MA, Yang Y, Zhang L, et al. Insulin resistance, cardiovascular stiffening and cardiovascular disease. Metabolism. 2021;119: 154766.PubMedCrossRef
20.
go back to reference Engin A. The definition and prevalence of obesity and metabolic syndrome. Adv Exp Med Biol. 2017;960:1–17.PubMedCrossRef Engin A. The definition and prevalence of obesity and metabolic syndrome. Adv Exp Med Biol. 2017;960:1–17.PubMedCrossRef
21.
go back to reference Yang Y, Kurian J, Schena G, et al. Cardiac Remodeling during pregnancy with metabolic syndrome: prologue of pathological remodeling. Circulation. 2021;143(7):699–712.PubMedPubMedCentralCrossRef Yang Y, Kurian J, Schena G, et al. Cardiac Remodeling during pregnancy with metabolic syndrome: prologue of pathological remodeling. Circulation. 2021;143(7):699–712.PubMedPubMedCentralCrossRef
22.
go back to reference Reaven GM. Relationships among insulin resistance, type 2 diabetes, essential hypertension, and cardiovascular disease: similarities and differences. J Clin Hypertens. 2011;13(4):238–43.CrossRef Reaven GM. Relationships among insulin resistance, type 2 diabetes, essential hypertension, and cardiovascular disease: similarities and differences. J Clin Hypertens. 2011;13(4):238–43.CrossRef
23.
go back to reference Rattanatham R, Tangpong J, Chatatikun M, et al. Assessment of eight insulin resistance surrogate indexes for predicting metabolic syndrome and hypertension in Thai law enforcement officers. PeerJ. 2023;11: e15463.PubMedPubMedCentralCrossRef Rattanatham R, Tangpong J, Chatatikun M, et al. Assessment of eight insulin resistance surrogate indexes for predicting metabolic syndrome and hypertension in Thai law enforcement officers. PeerJ. 2023;11: e15463.PubMedPubMedCentralCrossRef
24.
go back to reference Bello-Chavolla OY, Almeda-Valdes P, Gomez-Velasco D, et al. METS-IR, a novel score to evaluate insulin sensitivity, is predictive of visceral adiposity and incident type 2 diabetes. Eur J Endocrinol. 2018;178(5):533–44.PubMedCrossRef Bello-Chavolla OY, Almeda-Valdes P, Gomez-Velasco D, et al. METS-IR, a novel score to evaluate insulin sensitivity, is predictive of visceral adiposity and incident type 2 diabetes. Eur J Endocrinol. 2018;178(5):533–44.PubMedCrossRef
25.
go back to reference Wang Z, Hui X, Huang X, et al. Relationship between a novel non-insulin-based metabolic score for insulin resistance (METS-IR) and coronary artery calcification. BMC Endocr Disord. 2022;22(1):274.PubMedPubMedCentralCrossRef Wang Z, Hui X, Huang X, et al. Relationship between a novel non-insulin-based metabolic score for insulin resistance (METS-IR) and coronary artery calcification. BMC Endocr Disord. 2022;22(1):274.PubMedPubMedCentralCrossRef
26.
go back to reference Cheng L, Zhang F, Xue W, et al. Association of dynamic change of triglyceride-glucose index during hospital stay with all-cause mortality in critically ill patients: a retrospective cohort study from MIMIC IV2.0. Cardiovasc Diabetol. 2023;22(1):142.PubMedPubMedCentralCrossRef Cheng L, Zhang F, Xue W, et al. Association of dynamic change of triglyceride-glucose index during hospital stay with all-cause mortality in critically ill patients: a retrospective cohort study from MIMIC IV2.0. Cardiovasc Diabetol. 2023;22(1):142.PubMedPubMedCentralCrossRef
27.
go back to reference Tao LC, Xu JN, Wang TT, et al. Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations[J]. Cardiovasc Diabetol. 2022;21(1):68.PubMedPubMedCentralCrossRef Tao LC, Xu JN, Wang TT, et al. Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations[J]. Cardiovasc Diabetol. 2022;21(1):68.PubMedPubMedCentralCrossRef
28.
go back to reference Detection EEPO, Adults TOHBCI. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). Circulation. 2001;106(19):3143–421. Detection EEPO, Adults TOHBCI. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). Circulation. 2001;106(19):3143–421.
29.
go back to reference Arbab-Zadeh A, Fuster V. The risk continuum of atherosclerosis and its implications for defining CHD by coronary angiography. J Am Coll Cardiol. 2016;68(22):2467–78.PubMedCrossRef Arbab-Zadeh A, Fuster V. The risk continuum of atherosclerosis and its implications for defining CHD by coronary angiography. J Am Coll Cardiol. 2016;68(22):2467–78.PubMedCrossRef
30.
go back to reference Cesari M, Rossi GP, Sticchi D, et al. Is homocysteine important as risk factor for coronary heart disease? Nutr Metab Cardiovasc Dis. 2005;15(2):140–7.PubMedCrossRef Cesari M, Rossi GP, Sticchi D, et al. Is homocysteine important as risk factor for coronary heart disease? Nutr Metab Cardiovasc Dis. 2005;15(2):140–7.PubMedCrossRef
31.
go back to reference Simental-Mendia LE, Rodriguez-Moran M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6(4):299–304.PubMedCrossRef Simental-Mendia LE, Rodriguez-Moran M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6(4):299–304.PubMedCrossRef
33.
go back to reference James DE, Stockli J, Birnbaum MJ. The aetiology and molecular landscape of insulin resistance. Nat Rev Mol Cell Biol. 2021;22(11):751–71.PubMedCrossRef James DE, Stockli J, Birnbaum MJ. The aetiology and molecular landscape of insulin resistance. Nat Rev Mol Cell Biol. 2021;22(11):751–71.PubMedCrossRef
34.
35.
go back to reference Al-Muzafar HM, Alshehri FS, Amin KA. The role of pioglitazone in antioxidant, anti-inflammatory, and insulin sensitivity in a high fat-carbohydrate diet-induced rat model of insulin resistance. Braz J Med Biol Res. 2021;54(8): e10782.PubMedPubMedCentralCrossRef Al-Muzafar HM, Alshehri FS, Amin KA. The role of pioglitazone in antioxidant, anti-inflammatory, and insulin sensitivity in a high fat-carbohydrate diet-induced rat model of insulin resistance. Braz J Med Biol Res. 2021;54(8): e10782.PubMedPubMedCentralCrossRef
36.
go back to reference Li S, He J, Zhang X, et al. Cardiovascular adverse events in chronic myeloid leukemia patients treated with nilotinib or imatinib: a systematic review, meta-analysis and integrative bioinformatics analysis. Front Cardiovasc Med. 2022;9: 966182.PubMedPubMedCentralCrossRef Li S, He J, Zhang X, et al. Cardiovascular adverse events in chronic myeloid leukemia patients treated with nilotinib or imatinib: a systematic review, meta-analysis and integrative bioinformatics analysis. Front Cardiovasc Med. 2022;9: 966182.PubMedPubMedCentralCrossRef
37.
go back to reference Liang S, Wang C, Zhang J, et al. Triglyceride-glucose index and coronary artery disease: a systematic review and meta-analysis of risk, severity, and prognosis. Cardiovasc Diabetol. 2023;22(1):170.PubMedPubMedCentralCrossRef Liang S, Wang C, Zhang J, et al. Triglyceride-glucose index and coronary artery disease: a systematic review and meta-analysis of risk, severity, and prognosis. Cardiovasc Diabetol. 2023;22(1):170.PubMedPubMedCentralCrossRef
38.
go back to reference Lee EY, Yang HK, Lee J, et al. Triglyceride glucose index, a marker of insulin resistance, is associated with coronary artery stenosis in asymptomatic subjects with type 2 diabetes. Lipids Health Dis. 2016;15(1):155.PubMedPubMedCentralCrossRef Lee EY, Yang HK, Lee J, et al. Triglyceride glucose index, a marker of insulin resistance, is associated with coronary artery stenosis in asymptomatic subjects with type 2 diabetes. Lipids Health Dis. 2016;15(1):155.PubMedPubMedCentralCrossRef
39.
go back to reference Wang X, Xu W, Song Q, et al. Association between the triglyceride-glucose index and severity of coronary artery disease. Cardiovasc Diabetol. 2022;21(1):168.PubMedPubMedCentralCrossRef Wang X, Xu W, Song Q, et al. Association between the triglyceride-glucose index and severity of coronary artery disease. Cardiovasc Diabetol. 2022;21(1):168.PubMedPubMedCentralCrossRef
40.
go back to reference Thai PV, Tien HA, Van Minh H, et al. Triglyceride glucose index for the detection of asymptomatic coronary artery stenosis in patients with type 2 diabetes. Cardiovasc Diabetol. 2020;19(1):137.PubMedPubMedCentralCrossRef Thai PV, Tien HA, Van Minh H, et al. Triglyceride glucose index for the detection of asymptomatic coronary artery stenosis in patients with type 2 diabetes. Cardiovasc Diabetol. 2020;19(1):137.PubMedPubMedCentralCrossRef
41.
go back to reference Zhao Q, Zhang TY, Cheng YJ, et al. Impacts of triglyceride-glucose index on prognosis of patients with type 2 diabetes mellitus and non-ST-segment elevation acute coronary syndrome: results from an observational cohort study in China. Cardiovasc Diabetol. 2020;19(1):108.PubMedPubMedCentralCrossRef Zhao Q, Zhang TY, Cheng YJ, et al. Impacts of triglyceride-glucose index on prognosis of patients with type 2 diabetes mellitus and non-ST-segment elevation acute coronary syndrome: results from an observational cohort study in China. Cardiovasc Diabetol. 2020;19(1):108.PubMedPubMedCentralCrossRef
42.
go back to reference Li M, Zhan A, Huang X, et al. Positive association between triglyceride glucose index and arterial stiffness in hypertensive patients: the China H-type hypertension registry study. Cardiovasc Diabetol. 2020;19(1):139.PubMedPubMedCentralCrossRef Li M, Zhan A, Huang X, et al. Positive association between triglyceride glucose index and arterial stiffness in hypertensive patients: the China H-type hypertension registry study. Cardiovasc Diabetol. 2020;19(1):139.PubMedPubMedCentralCrossRef
43.
go back to reference Song S, Choi SY, Park HE, et al. Incremental prognostic value of triglyceride glucose index additional to coronary artery calcium score in asymptomatic low-risk population[J]. Cardiovasc Diabetol. 2022;21(1):193.PubMedPubMedCentralCrossRef Song S, Choi SY, Park HE, et al. Incremental prognostic value of triglyceride glucose index additional to coronary artery calcium score in asymptomatic low-risk population[J]. Cardiovasc Diabetol. 2022;21(1):193.PubMedPubMedCentralCrossRef
44.
go back to reference Park K, Ahn CW, Lee SB, et al. Elevated TyG index predicts progression of coronary artery calcification. Diabetes Care. 2019;42(8):1569–73.PubMedCrossRef Park K, Ahn CW, Lee SB, et al. Elevated TyG index predicts progression of coronary artery calcification. Diabetes Care. 2019;42(8):1569–73.PubMedCrossRef
45.
go back to reference Lin CP, Lin FY, Huang PH, et al. Endothelial progenitor cell dysfunction in cardiovascular diseases: role of reactive oxygen species and inflammation. Biomed Res Int. 2013;2013: 845037.PubMedCrossRef Lin CP, Lin FY, Huang PH, et al. Endothelial progenitor cell dysfunction in cardiovascular diseases: role of reactive oxygen species and inflammation. Biomed Res Int. 2013;2013: 845037.PubMedCrossRef
46.
go back to reference Kim JA, Kim J, Roh E, et al. Triglyceride and glucose index and the risk of gestational diabetes mellitus: a nationwide population-based cohort study. Diabetes Res Clin Pract. 2021;171: 108533.PubMedCrossRef Kim JA, Kim J, Roh E, et al. Triglyceride and glucose index and the risk of gestational diabetes mellitus: a nationwide population-based cohort study. Diabetes Res Clin Pract. 2021;171: 108533.PubMedCrossRef
47.
go back to reference Gui J, Li Y, Liu H, et al. Obesity- and lipid-related indices as a predictor of obesity metabolic syndrome in a national cohort study. Front Public Health. 2023;11:1073824.PubMedPubMedCentralCrossRef Gui J, Li Y, Liu H, et al. Obesity- and lipid-related indices as a predictor of obesity metabolic syndrome in a national cohort study. Front Public Health. 2023;11:1073824.PubMedPubMedCentralCrossRef
48.
go back to reference Zhao J, Fan H, Wang T, et al. TyG index is positively associated with risk of CHD and coronary atherosclerosis severity among NAFLD patients. Cardiovasc Diabetol. 2022;21(1):123.PubMedPubMedCentralCrossRef Zhao J, Fan H, Wang T, et al. TyG index is positively associated with risk of CHD and coronary atherosclerosis severity among NAFLD patients. Cardiovasc Diabetol. 2022;21(1):123.PubMedPubMedCentralCrossRef
49.
go back to reference Liu D, Yang K, Gu H, et al. Predictive effect of triglyceride-glucose index on clinical events in patients with acute ischemic stroke and type 2 diabetes mellitus. Cardiovasc Diabetol. 2022;21(1):280.PubMedPubMedCentralCrossRef Liu D, Yang K, Gu H, et al. Predictive effect of triglyceride-glucose index on clinical events in patients with acute ischemic stroke and type 2 diabetes mellitus. Cardiovasc Diabetol. 2022;21(1):280.PubMedPubMedCentralCrossRef
50.
go back to reference Liu X, Abudukeremu A, Jiang Y, et al. U-shaped association between the triglyceride-glucose index and atrial fibrillation incidence in a general population without known cardiovascular disease. Cardiovasc Diabetol. 2023;22(1):118.PubMedPubMedCentralCrossRef Liu X, Abudukeremu A, Jiang Y, et al. U-shaped association between the triglyceride-glucose index and atrial fibrillation incidence in a general population without known cardiovascular disease. Cardiovasc Diabetol. 2023;22(1):118.PubMedPubMedCentralCrossRef
51.
go back to reference Yu H, Tao L, Li YG, et al. Association between triglyceride-glucose index trajectories and carotid atherosclerosis progression. Cardiovasc Diabetol. 2023;22(1):130.PubMedPubMedCentralCrossRef Yu H, Tao L, Li YG, et al. Association between triglyceride-glucose index trajectories and carotid atherosclerosis progression. Cardiovasc Diabetol. 2023;22(1):130.PubMedPubMedCentralCrossRef
52.
go back to reference Han M, Wang H, Yang S, et al. Triglyceride glucose index and Atherogenic index of plasma for predicting colorectal neoplasms in patients without cardiovascular diseases. Front Oncol. 2022;12:1031259.PubMedPubMedCentralCrossRef Han M, Wang H, Yang S, et al. Triglyceride glucose index and Atherogenic index of plasma for predicting colorectal neoplasms in patients without cardiovascular diseases. Front Oncol. 2022;12:1031259.PubMedPubMedCentralCrossRef
53.
go back to reference Fritz J, Brozek W, Concin H, et al. The triglyceride-glucose index and obesity-related risk of end-stage kidney disease in austrian adults. JAMA Netw Open. 2021;4(3): e212612.PubMedPubMedCentralCrossRef Fritz J, Brozek W, Concin H, et al. The triglyceride-glucose index and obesity-related risk of end-stage kidney disease in austrian adults. JAMA Netw Open. 2021;4(3): e212612.PubMedPubMedCentralCrossRef
54.
go back to reference Luo E, Wang D, Yan G, et al. High triglyceride-glucose index is associated with poor prognosis in patients with acute ST-elevation myocardial infarction after percutaneous coronary intervention. Cardiovasc Diabetol. 2019;18(1):150.PubMedPubMedCentralCrossRef Luo E, Wang D, Yan G, et al. High triglyceride-glucose index is associated with poor prognosis in patients with acute ST-elevation myocardial infarction after percutaneous coronary intervention. Cardiovasc Diabetol. 2019;18(1):150.PubMedPubMedCentralCrossRef
55.
go back to reference Rawshani A, Rawshani A, Franzen S, et al. Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med. 2018;379(7):633–44.PubMedCrossRef Rawshani A, Rawshani A, Franzen S, et al. Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med. 2018;379(7):633–44.PubMedCrossRef
56.
go back to reference Yu C, Wang T, Zhou W, et al. Positive association between the triglyceride-glucose index and hyperuricemia in chinese adults with hypertension: an insight from the china h-type hypertension registry study. Int J Endocrinol. 2022;2022:4272715.PubMedPubMedCentralCrossRef Yu C, Wang T, Zhou W, et al. Positive association between the triglyceride-glucose index and hyperuricemia in chinese adults with hypertension: an insight from the china h-type hypertension registry study. Int J Endocrinol. 2022;2022:4272715.PubMedPubMedCentralCrossRef
57.
go back to reference Hu L, Bao H, Huang X, et al. relationship between the triglyceride glucose index and the risk of first stroke in elderly hypertensive patients. Int J Gen Med. 2022;15:1271–9.PubMedPubMedCentralCrossRef Hu L, Bao H, Huang X, et al. relationship between the triglyceride glucose index and the risk of first stroke in elderly hypertensive patients. Int J Gen Med. 2022;15:1271–9.PubMedPubMedCentralCrossRef
59.
go back to reference Lavie CJ, Mcauley PA, Church TS, et al. Obesity and cardiovascular diseases: implications regarding fitness, fatness, and severity in the obesity paradox. J Am Coll Cardiol. 2014;63(14):1345–54.PubMedCrossRef Lavie CJ, Mcauley PA, Church TS, et al. Obesity and cardiovascular diseases: implications regarding fitness, fatness, and severity in the obesity paradox. J Am Coll Cardiol. 2014;63(14):1345–54.PubMedCrossRef
Metadata
Title
Relationship between TyG index and the degree of coronary artery lesions in patients with H-type hypertension
Authors
Zhengwen Xu
Peixian Chen
Lian Wang
Jie Yan
Xisheng Yan
Dongsheng Li
Publication date
01-12-2024
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2024
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/s12933-023-02013-0

Other articles of this Issue 1/2024

Cardiovascular Diabetology 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine